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Cyclooxygenase-2 (COX-2), the inducible form of COX, is overexpressed in
early and advanced colorectal cancers and is associated with a poor prognosis.
1,2
Overexpression of COX-2 or treatment with prostaglandin E2 (PGE2) is related to
carcinogenesis via immunosuppression, inhibition of apoptosis, increasing the
metastatic potential of epithelial cells, and by promoting angiogenesis.
1,2 Conversely,
treatment with selective COX-2 inhibitors results in a significant decrease in
colorectal adenomas in humans and animals.
1,2
Cell-cell adhesion mediated by E-cadherin is required for the maintenance of
epithelial tissue architecture in adult organisms.
3 Down-modulation of E-cadherin
is observed during the later stages of tumorigenesis.
4 This down-regulation of E-
cadherin is accompanied by a loss of epithelial characteristics and the acquisition
of mesenchymal properties, a process often referred to as the epithelial-to-
mesenchymal transition (EMT).
4 During EMT, carcinoma cells become more
motile and invasive by acquiring characteristics similar to embryonic mesenchymal
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INTRODUCTIONcells, thereby allowing penetration of the stroma surround-
ing the initial neoplastic focus.
5 Control of E-cadherin gene
transcription is the primary mechanism accounting for the
down-regulation of this protein. The zinc finger factor
Snail is a strong repressor of E-cadherin transcription and a
well known inducer of EMT. Snail is specifically over-
expressed in the tumor cells located at the invasive front. It
is responsible for the disruption of E-cadherin mediated
cell-cell contacts, invasion, the reduction of tumor prolifera-
tive activity, as well as the gain of resistance to apoptosis.
6,7
Other E-cadherin repressors that have been implicated in
EMT are the Snail family member Slug, the basic helix-
loop-helix factors E47 and Twist, and the two-handed zinc
factors zinc finger E-box-binding homeobox 1 (ZEB1) and
and smad-interacting protein 1 (SIP1).
5,6
Tsujii and Dubois
8 demonstrated that the COX-2 overex-
pression was linked to inactivation of E-cadherin. A recent
study showed that COX-2 and PGE2 expressions in lung
cancer cells resulted in a significant reduction of E-cadherin
via a ZEB1 and Snail transcriptional factor mediated mecha-
nism, and that inhibition of COX-2 resulted in rescue of E-
cadherin expression.
9 PGE2 is inactivated by prostaglandin
dehydrogenase (PGDH). In human colon cancers, elevated
Snail expression correlates well with down-regulation of
PGDH.
10 Here, we investigated the relationship between E-
cadherin and COX-2 in colon cancer cell lines and human
colon cancer tissues. 
Cell culture, reagents, and drug treatment
Three colon cancer cell lines (HCT8, HT29, SW620) were
obtained from the Korean Cell Line Bank (Seoul, Korea)
and grown in RPMI 1640 (Life Technologies, Inc., Gai-
thersburg, MD, USA) supplemented with 10% fetal bovine
serum (Life Technologies, Inc.) and gentamicin (10 µg/mL)
in a 5% CO2 humidified atmosphere. PGE2 and phorbol
12-myristate 13-acetate (PMA) were purchased from
Sigma (St. Louis, MO, USA) and dissolved in absolute
ethanol and dimethyl sulfoxide, respectively.
Transfection of Snail and COX-2 cDNA
HCT8 and SW620 cells (2×10
5 in 2 mL of RPMI 1640
without gentamicin) were plated in 6-well plates. Twenty-
four hours later the cells were transfected with vector alone
or with 4 µg of pcDNA3.1-Snail (a gift of Dr. Yook, College
of Medicine, Yonsei University, Seoul, Korea) or pCB7-
rat COX-2 (a gift of Dr DuBois, Vanderbilt University,
TN, USA) using Lipofectamine 2000 (Life Technologies,
Inc.) according to the manufacturer’s instructions. Briefly,
4 µg of DNA was mixed with 250 µL of Opti-MEM I (Life
Technologies, Inc.). The diluted DNA was combined with
10 µL of Lipofectamine 2000 diluted by 250 µL of Opti-
MEM I (Life Technologies, Inc.) and incubated for 20
minutes at room temperature. This mixture was added to
cells that had attained 90% confluence in 6-well plates.
After 48 hours, the cells were harvested for Western blot
analysis.
Western blot analysis
Cells were washed with cold phosphate buffer solution
(PBS) and suspended in lysis buffer (1×PBS, 1% Triton
X-100) supplemented with complete mini protease inhibitor
mixture tablets (Boehringer Mannheim, Mannheim,
Germany) on ice for 30 minutes. After removing cell debris
by centrifugation, cell lysate protein concentrations were
determined using BCA protein assay reagent (Pierce,
Rockford, IL, USA) with bovine serum albumin as a
standard. Forty µg of protein was separated by 12% SDS-
polyacrylamide gel and transferred to a nitrocellulose
membrane. The membranes were blocked with 5% skim
milk in Tris buffered saline (TBS) for 1 hour at room
temperature and probed with antibodies overnight at 4˚C.
The antibodies used were anti-COX-2 (1 : 1000; Cayman
Chemical, Ann Arbor, MI, USA), anti-15-PGDH (1 : 500;
Cayman Chemical), anti-E-cadherin (1 : 1000, Transduction
Laboratories, Lexington, KY, USA), anti-Snail (1 : 1000,
Abcam plc. Cambridge, UK) and anti-glyceraldehydes 3-
phosphate dehydrogenase (GAPDH) (1: 200, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA). After washing
with triethanolamine-buffered saline (TBS)-0.05% Tween
20, the blots were treated with a horseradish peroxidase-
conjugated anti-rabbit immunoglobulin G (IgG) antibody
(1 : 3000; Zymed Laboratories Inc., San Francisco, CA,
USA) or a anti-mouse IgG antibody (1 : 3000; Zymed
Laboratories Inc.) for 1 hour at room temperature. Detec-
tion was performed by enhanced chemiluminescence
(Pierce) and autoradiography.
RNA extraction and reverse transcription-polymerase
chain reaction
Total RNA was extracted and purified from HT29 cells
using a GeneElute Mammalian Total RNA kit (Sigma)
according to the manufacturer’s instructions. RNA was
quantified by measuring absorbance at 260 nm. Two µg of
the total RNA from each sample was reverse transcribed
into complementary DNA (cDNA) using Superscript II
reverse transcriptase (Life Technologies, Inc.) and random
hexamer primers (Takara, Shiga, Japan). The Polymerase
chain reaction (PCR) primers used were as follows (D) :
ZEB1, 5’-TTCAGCATCACCAGGCAGTC-3’ (sense),
5’-GAGTGGAGGAGGCTGAGTAG-3’ (antisense);
Snail, 5’-TTCCAGCAGCCCTACGACCAG-3’ (sense),
Role of COX-2 on EMT in Colon Cancers
Yonsei Med J   http://www.eymj.org    Volume 50   Number 6   December 2009 819
MATERIALS AND METHODS5’-GCCTTTCCCACTGTCCTCATC-3’ (antisense);
GAPDH, 5’-GAACGGGAAGCTCACTGGCATGGC-3’
(sense), 5’-AATGGTAATGTCAGCTGTATTACT-
3’(antisense).
11 The PCR conditions used were: 94˚C for 5
minutes, 30 cycles of amplification (94˚C for 45 seconds,
57˚C for 45 seconds, 72˚C for 45 seconds), and an addi-
tional extension step of 72˚C for 7 minutes. PCR products
were electrophoresed in a 1% agarose gel containing ethid-
ium bromide and then photographed under ultraviolet light.
Wound healing assay
Confluent cell monolayers were wounded by manually
scraping the cells with a pipette tip. Debris was removed
from the culture by washing it twice with PBS. The cells
were then incubated with serum-free medium including
either PGE2 (5 µg/mL) or PMA (50 ng/mL) and allowed to
migrate into the wounded area for up to 24 hours at 37˚C.
Images were immediately acquired at 4 hours and 24 hours
after wounding. This test was performed in triplicate.
Tissue samples and immunohistochemistry
We used 66 paraffin-embedded primary colon cancers
(age range 31-92 years; 30 male and 36 female), 25 metas-
tatic lymph nodes, and 10 adenomas (age range 35-60
years; 5 male and 5 female) obtained from the Department
of Pathology at Dongguk University Kyongju Hospital.
Formalin fixed paraffin embedded tissue sections of 4 µm
thickness were made and spread on poly-L-lysine coated
slides. The sections were deparaffinized and hydrated in a
graded series of alcohol. Antigen retrieval was routinely
performed by immersing the sections in 0.01 M citrate
buffer (pH 6.0) in a pressure cooker by autoclaving for 15
minutes. Endogenous peroxidase activity was blocked with
3% hydrogen peroxide for 15 minutes and then incubated
with a primary antibody for 2 hours at room temperature.
The primary antibodies used were: anti-COX-2 (Cayman
Chemical, dilution 1 : 500), -E-cadherin (1 : 1000, Trans-
duction Laboratories), and anti-Snail (1 : 500, Abcam plc).
Staining was done with an EnVision kit labeled with
peroxidase (DAKO, Santa Barbara, CA, USA) and devel-
oped with 3, 3’-diaminobenzidine tetrahydrochloride
(Zymed Laboratories, South San Franciso, CA, USA) as a
chromogen. Sections were counterstained for 3 minutes
with Mayer’s hematoxylin and then mounted. As a nega-
tive control, rabbit or mouse IgG isotype was used instead
of primary antibody. 
We assessed immunohistochemical staining in only
epithelial and tumor cells. Immunohistochemical staining
for Snail was defined as a detectable immunoreaction in the
nucleus. Immunoreactivity of COX-2 and Snail was evalu-
ated by assessing the proportion of positive cells and graded
as absence (no staining), mild (1-30%), moderate (31-60%),
or severe (> 60%). Four immunohistochemical staining
grades were divided into a positive (moderate and severe)
and a negative one (absence and mild) for statistical analy-
sis. Membranous E-cadherin expression was graded accord-
ing to the proportion of positive cells and classified into a
positive group (> 90%) and an abnormal group (0-90%).
Statistical analysis
Chi-square and Fisher exact test were used. Statistical
significance was considered for a pvalue < 0.05.
We performed immunoblot analyses for E-cadherin, Snail,
and COX-2 in colon cancer cell lines. As shown in Fig.
1A, E-cadherin expressions were higher in HCT8 and
HT29 than in SW620, which had strong expressions of
Snail and COX-2. In order to verify these findings, HCT8
and SW620 were transfected with cDNA for either COX-2
or Snail, and then harvested after 48 hours. As shown in
Fig. 1B and C, ectopic expression of COX-2 or Snail reduced
E-cadherin in HCT8 and SW620, and induced a scattered,
flattened phenotype with few intercellular contacts in
HCT8. As shown in Fig. 2A, PMA treatment (50 ng/mL)
increased the expressions of COX-2 and Snail, and de-
creased the expressions of E-cadherin and PGDH in HCT8.
Similar findings were observed in HT29 except for COX-
2. The expression of COX-2 was not altered under PMA
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RESULTS
Fig. 1. Western blot analyses of E-cadherin, COX-2 and Snail in colon cancer
cells, and morphology of HCT8 transfected with cDNA for COX-2 or Snail. (A and
B) Endogenous expressions of E-cadherin, COX-2, and Snail in colon cancer
cells, and ectopic expressions of COX-2 and Snail in HCT8 and SW620. Forty µg
of protein was separated by 10% SDS-polyacrylamide gel electrophoresis and
transferred to a nitrocellulose membrane. The bottom represents GAPDH,
which was used as a loading control. (C) Ectopic expression of COX-2 or Snail
induced a scattered, flattened phenotype with few intercellular contacts in
HCT8. COX-2, cyclooxygenase-2; SDS, sodium dodecyl sulfate; cDNA, comple-
mentary DNA; GAPDH, glyceraldehydes 3-phosphate dehydrogenase.
A B
Cexposure. Wound healing assays were performed to exa-
mine the effects of PMA on cancer cells’ motility. As shown
in Fig. 2B, PMA treatment increased cell motility in HCT8
and HT29. These results suggest that there is a close asso-
ciation between PG metabolism and cell migration. Thus,
we examined the effect of PGE2 treatment on cell motility.
As shown in Fig 3, PGE2 exposure for 24 hours increased
Snail expression and decreased E-cadherin in HCT8.
However, PGE2 exposure did not alter the expression of E-
cadherin and slightly increased Snail expression in HT 29.
Cell motility was increased in HCT8 and HT29 cells treated
with PGE2 (5 µg/mL). As the alteration of Snail expression
was weak in HT29 treated with PMA, we examined the
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Fig. 2. Effects of PMA on the expressions of E-cadherin, COX-2, Snail and 15-
PGDH, and cell mobility in HCT8 and HT29. (A) Western blot analyses for E-
cadherin, COX-2, Snail and 15-PGDH in the presence of PMA (50 ng/mL) at the
indicated times. Forty µg of protein was separated by 10% SDS-polyacrylamide
gel electrophoresis and transferred to a nitrocellulose membrane. The bottom
represents GAPDH, which was used as a loading control. (B) Cells were
incubated with serum-free medium including PMA (50 ng/mL) and allowed to
migrate into the wound area for up to 24 hours at 37˚C. Images were acquired
immediately, and at 4 hours and 24 hours after wounding. PMA (50 ng/mL)
treatment increased cell mobility in HCT8 and HT29. COX-2, cyclooxygenase-2;
GAPDH, glyceraldehydes 3-phosphate dehydrogenase; PMA, phorbol 12-
myristate 13-acetate; 15-PGDH, 15-hydroxyprostaglandin dehydrogenase.
A
B
Fig. 4. mRNA expressions for snail and ZEB1 by RT-PCR in HT29 treated with
PMA (50 ng/mL) or PGE2(5 µg/mL for 24 hours. mRNA, messenger RNA; RT-PCR,
reverse transcription-polymerase chain reaction; PMA, phorbol 12-myristate 13-
acetate; PGE2, prostaglandin E2. 
Fig. 3. Effects of PGE2 on the expressions of E-cadherin and Snail, and cell
mobility in HCT8 and HT29. (A) Western blot analyses for E-cadherin and Snail in
the presence of PGE2at the indicated doses for 24 hours. Forty µg of protein was
separated by 10% SDS-polyacrylamide gel electrophoresis and transferred to a
nitrocellulose membrane. The bottom represents GAPDH, which was used as a
loading control. (B) Cells were incubated with serum-free medium including with
PGE2(5 µg/mL) and allowed to migrate into the wound area for up to 24 hours at
37˚C. Images were acquired immediately, and at 24 hours after wounding. PGE2
(5 µg/mL) treatment increased cell mobility in HCT8 and HT29. GAPDH,
glyceraldehydes 3-phosphate dehydrogenase; PGE2, prostaglandin E2. SDS,
sodium dodecyl sulfate.
A
B
Table 1. Summary of Immunohistochemical Results of E-Cadherin, Snail and COX-2 in Non-Neoplastic 
Epithelium, Adenomas, and Cancers
Non-neoplastic epithelium (n) Adenomas (n) Cancers (n)
E-cadherin Abnormal 0 8 51
Positive 76 2 15
Snail
Negative Absence 0 0 0
Mild 76 10 24
Positive Moderate 0 0 30
Severe 0 0 12
COX-2
Negative Absence 64 6 12
Mild 0 4 26
Positive Moderate 12 0 28
Severe 0 0 0  messenger RNA (mRNA) levels of Snail and ZEB1 in
HT29. As shown in Fig. 4, mRNA levels of snail and ZEB1
were increased in cells treated with either PMA or PGE2.
Immunohistochemical results for E-cadherin, COX-2
and Snail in non-neoplastic epithelium, adenomas, and
colon cancers are summarized in Table 1. An immuno-
positive result for membranous E-cadherin was 100% in
adjacent non-neoplastic epithelium, 20% in adenomas, and
23% in cancers. As shown in Fig. 5A, membranous E-
cadherin expressions were significantly more abnormal in
cancers and adenomas than in non-neoplastic epithelium (p
< 0.001). Immunoreactivity for Snail was mild in 100% of
non-neoplastic epithelium and adenomas, and in cancers it
was mild in 36%, moderate in 45% and severe in 18%.
Immunoreactivity for COX-2 in non-neoplastic epithelium
was absent in 84% and moderate in 16%, and in adenomas,
it was absent in 60% and mild in 40%, and in cancers, it
was absent in 18%, mild in 39%, and moderated in 42%.
As shown in Fig. 5E and 5I, the expressions of Snail and
COX-2 were significantly higher in cancers than in adeno-
mas and non-neoplastic epithelium (p < 0.05). The immu-
nopositive results for COX-2 were 14% in stages 0 and I
and 50% in stages II-IV. COX-2 expression was signifi-
cantly related to a higher tumor stage (p = 0.016). There
were no significant differences between tumor stage and
the immunopositive results for Snail and membranous E-
cadherin. We examined the immunoreacitivities of mem-
branous E-cadherin, COX-2, and Snail in primary cancers
and metastatic lesions of lymph nodes. COX-2 was
immunopositive in 42% of primary cancers and 71% of
nodal tumors. As shown in Fig. 6, COX-2 expression was
significantly higher in nodal metastatic lesions than
primary tumors (p = 0.021). There were no significant
differences in the expressions of membranous E-cadherin
and Snail between primary cancers and nodal metastatic
lesions. As shown in Fig. 7, membranous E-cadherin was
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Fig. 5. Immunohistochemical staining for E-cadherin (B, C, D), COX-2 (F, G, H) and Snail (J, K, M) in non-neoplastic adjacent mucosa (B, F, J),
adenomas (C, G, K), and cancers (D, H, M). (A) Membranous E-cadherin expressions were significantly abnormal in cancers and adenomas than in
non-neoplastic epithelium (p< 0.001). (E, I) In contrast, Snail and COX-2 expressions were significantly higher in cancers than in adenomas and
non-neoplastic epithelium (p< 0.05, p< 0.001). COX-2, cyclooxygenase-2.
B
F
J
C
G
K
D
H
L
A
E
I
Fig. 6. Immunohistochemical staining for COX-2 in nodal metastatic (B) and primary cancers (C). (A) COX-2 expression was significantly higher in
nodal metastatic lesions than primary cancers (p= 0.021). COX-2, cyclooxygenase-2.
BC Apredominantly expressed at a tumor center, where COX-2
and Snail were weakly expressed. In contrast, COX-2 and
Snail were frequently expressed at the invasive front area,
where membranous E-cadherin expression was abnormal.
EMT occurs via 2 distinct biological events: the breaking
of cell-cell adhesions and a consequent increase in cell
motility.
12 A defining characteristic of EMT is the loss of
E-cadherin.
4 The loss of E-cadherin occurring during
carcinoma progression can take place through gene muta-
tions, hypermethylation of its promoter, and transcriptional
repression.
13 E-cadherin repressors that have been implicated
in EMT are the Snail family, the basic helix-loop-helix
factors E47 and Twist, and the two-handed zinc factors
ZEBl and SIPl.
6
In this study, we observed that E-cadherin expression
was inversely related to the expressions of COX-2 and
Snail in colon cancer cells. Ectopic expression of COX-2
or Snail reduced E-cadherin and induced a scattered, flat-
tened phenotype with few intercellular contacts in colon
cancer cells. PMA treatment for cancer cells increased the
cells’ motility associated with increased expressions of
COX-2 and Snail, and a reduction of PGDH expression.
PGE2 exposure also increased Snail expression and cell
motility, and decreased E-cadherin expression. Tsujii and
Dubois
8 have demonstrated that COX-2 overexpression in
rat intestinal epithelial cells leads to increased adhesion to
extracellular matrix related to loss of E-cadherin expression.
E-cadherin was upregulated and localized at intercellular
junctions and the cytoplasmic membrane in etodolac-
stimulated Caco-2 colon cancer cells.
14 Recent studies of
non-small cell lung cancer and colon cancer have shown
that augmentation of PGE2 by COX-2 activation or PGDH
inactivation repressed E-cadherin expression through the
induction of Snail and ZEB1.
9,10 In colon cancer cells, the
RhoA/Rho kinase pathway stimulated by COX-2 reduced
the levels of E-cadherin and α-catenin leading to a disrup-
tion of adherens junction formation and increased cell
motility.
15 These findings suggest that COX-2 is related to
the invasion and metastasis of cancer cells through EMT. 
We performed immunohistochemistry for E-cadherin,
COX-2, and Snail in primary and metastatic nodal tumors
in order to examine their biologic roles. A reduction or loss
of E-cadherin expression together with increased COX-2
expression has been reported in colorectal cancers.
16 We
observed similar results in colon cancers. Previous studies
also reported that high expression of COX-2 correlated
with a more advanced Dukes’ stage.
17-19 Our study showed
that COX-2 immunopositivity was significantly related to
higher tumor stages, and was significantly higher in nodal
metastatic lesions than primary cancers. Moreover, in
primary cancer lesions, COX-2 and Snail were predomi-
nantly expressed at the invasive front, where E-cadherin
expression was abnormal. Overall, the reduction or loss of
E-cadherin expression, together with increased COX-2
expression, plays an important role for the progression of
colon cancers. Based on our in vitro findings in colon cancer
cells, we sought to determine if the reciprocal expressions
of E-cadherin and COX-2 were evident in cancer cells in
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DISCUSSION
Fig. 7. Topographic distributions of E-cadherin (A, D), Snail (B, E), and COX-2 (C, F) in colon cancers by immunohistochemistry. (A, B and C)
Expressions of COX-2 and Snail were decreased in the areas with positive expression of E-cadherin. (D, E, F) In contrast, expressions of COX-2 and
Snail increased in the areas with abnormal E-cadherin expression (D). COX-2, cyclooxygenase-2.
A B C
D E Fsitu. As shown in Fig. 7, expressions of COX-2 and Snail
increased in the areas with abnormal E-cadherin expression.
This finding was also reported in non-small cell lung
cancers.
9
In conclusion, this study suggests that COX-2 may have
a role in the progression of colon cancer through EMT.
Thus, blocking PGE2 production or activity may contri-
bute to the treatment and prevention of colon cancer.
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